Healthcare Sector Ideas

[gfp927z]

Johnson & Johnson - >>> Johnson & Johnson is a healthcare giant that derives the majority of its growth from its pharmaceutical business. J&J boasts a large product lineup that includes immunology drugs Stelara and Tremfya and cancer drugs Darzalex and Erleada.


https://www.fool.com/investing/stock-market/market-sectors/healthcare/pharmaceutical-stocks/


The company’s pipeline features more than 50 late-stage clinical testing programs. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Darzalex and Imbruvica, which treat cancer.

Johnson & Johnson plans to spin off its consumer health unit into a standalone entity in 2023. This will leave the company with its two fastest-growing segments -- pharmaceutical and medical devices.

J&J ranks as a Dividend King, having raised its annual dividend for 59 consecutive years. Investors don’t have to worry about the dividend with the spinoff of the company’s consumer health business, though. J&J expects that its dividend, combined with the anticipated dividend from the new entity, will remain at least at the same level as before the transaction completes.

<<<



---